“every year a significant number of people carry SARS, caused by different viruses. Today we can exactly say past seasonal coronavirus does not give cross-immunity from COVID-19”, – said the head of the Ministry of health.
She also added that this is why Russia really hope I will get the vaccine before the start of the second wave of the disease.
Cross-immunity or cross-immunity – the state in which immunity to one organism also protects against other, related microorganism. For example, the world’s first vaccine against smallpox, used the immunity caused by the causative agent of cowpox, for successful fight against human smallpox.
As reported “Vesti”, according to the optimistic forecasts of the first clinical research for the first vaccine developed in the State research center of Virology and biotechnology “Vector”, expect to start in late June – early July and be completed in mid-September.
“One of the vaccine against the new coronavirus infection developed in the State research center of Virology and biotechnology “Vector” of Rospotrebnadzor, is intended for intranasal, it will drip into the nose” – this was in the movie told the General Director of the Rinat Maksyutov.
According to him, already running full-scale preclinical trial data of drugs in terms of effectiveness and safety.
for more acceleration, I’m sure Rinat Maksyutov, during the test vaccine is not required. He also said that the clinical trials developed at the center for vaccine COVID-19 will be conducted on volunteers of both sexes aged 18 to 60 years.
“People already ill with the novel coronavirus, to be volunteers in clinical trials of vaccines will not. Vaccine research from COVID-19 on children can begin at the beginning of 2021,” – said General Director of “Vector”.
